Vergara et al. (2015) demonstrated that, in AD patients with Braak stages I–VI, PrPC protein expression in the brain increases in the early stages of AD and peaks at approximately stage III. Thereafter, PrPC expression decreases until the manifestation of clinical symptoms in both cases (Vergara et al., 2015). The gene discussed is PRNP; the disease is Alzheimer disease.